BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36809767)

  • 1. Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia.
    Morini E; Chekuri A; Logan EM; Bolduc JM; Kirchner EG; Salani M; Krauson AJ; Narasimhan J; Gabbeta V; Grover S; Dakka A; Mollin A; Jung SP; Zhao X; Zhang N; Zhang S; Arnold M; Woll MG; Naryshkin NA; Weetall M; Slaugenhaupt SA
    Am J Hum Genet; 2023 Mar; 110(3):531-547. PubMed ID: 36809767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
    Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
    Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis in a humanized mouse model of familial dysautonomia reveals tissue-specific gene expression disruption in the peripheral nervous system.
    Harripaul R; Morini E; Salani M; Logan E; Kirchner E; Bolduc J; Chekuri A; Currall B; Yadav R; Erdin S; Talkowski ME; Gao D; Slaugenhaupt S
    Sci Rep; 2024 Jan; 14(1):570. PubMed ID: 38177237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis in a humanized mouse model of familial dysautonomia reveals tissue-specific gene expression disruption in the peripheral nervous system.
    Harripaul R; Morini E; Salani M; Logan E; Kirchner E; Bolduc J; Chekuri A; Currall B; Yadav R; Erdin S; Talkowski ME; Gao D; Slaugenhaupt S
    bioRxiv; 2023 Oct; ():. PubMed ID: 37808686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective retinal ganglion cell loss and optic neuropathy in a humanized mouse model of familial dysautonomia.
    Chekuri A; Logan EM; Krauson AJ; Salani M; Ackerman S; Kirchner EG; Bolduc JM; Wang X; Dietrich P; Dragatsis I; Vandenberghe LH; Slaugenhaupt SA; Morini E
    Hum Mol Genet; 2022 Jun; 31(11):1776-1787. PubMed ID: 34908112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia.
    Salani M; Urbina F; Brenner A; Morini E; Shetty R; Gallagher CS; Law EA; Sunshine S; Finneran DJ; Johnson G; Minor L; Slaugenhaupt SA
    SLAS Discov; 2019 Jan; 24(1):57-67. PubMed ID: 30085848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model.
    Donadon I; Pinotti M; Rajkowska K; Pianigiani G; Barbon E; Morini E; Motaln H; Rogelj B; Mingozzi F; Slaugenhaupt SA; Pagani F
    Hum Mol Genet; 2018 Jul; 27(14):2466-2476. PubMed ID: 29701768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA.
    Romano G; Riccardi F; Bussani E; Vodret S; Licastro D; Ragone I; Ronzitti G; Morini E; Slaugenhaupt SA; Pagani F
    Am J Hum Genet; 2022 Aug; 109(8):1534-1548. PubMed ID: 35905737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators.
    Schultz A; Cheng SY; Kirchner E; Costello S; Miettinen H; Chaverra M; King C; George L; Zhao X; Narasimhan J; Weetall M; Slaugenhaupt S; Morini E; Punzo C; Lefcort F
    Sci Rep; 2023 Oct; 13(1):18600. PubMed ID: 37903840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retina-specific loss of
    Ueki Y; Shchepetkina V; Lefcort F
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29929962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnosol, a diterpene present in rosemary, increases ELP1 levels in familial dysautonomia patient-derived cells and healthy adults: a possible therapy for FD.
    Anderson SL; Fasih-Ahmad F; Evans AJ; Rubin BY
    Hum Mol Genet; 2022 Oct; 31(20):3521-3538. PubMed ID: 35708500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
    Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
    Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental regulation of neuronal gene expression by Elongator complex protein 1 dosage.
    Morini E; Gao D; Logan EM; Salani M; Krauson AJ; Chekuri A; Chen YT; Ragavendran A; Chakravarty P; Erdin S; Stortchevoi A; Svejstrup JQ; Talkowski ME; Slaugenhaupt SA
    J Genet Genomics; 2022 Jul; 49(7):654-665. PubMed ID: 34896608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators.
    Schultz A; Cheng SY; Kirchner E; Costello S; Miettinen H; Chaverra M; King C; George L; Zhao X; Narasimhan J; Weetall M; Slaugenhaupt S; Morini E; Punzo C; Lefcort F
    bioRxiv; 2023 May; ():. PubMed ID: 37293016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone biomechanical properties and tissue-scale bone quality in a genetic mouse model of familial dysautonomia.
    Vahidi G; Flook H; Sherk V; Mergy M; Lefcort F; Heveran CM
    Osteoporos Int; 2021 Nov; 32(11):2335-2346. PubMed ID: 34036438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
    Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
    Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elp1 is required for development of visceral sensory peripheral and central circuitry.
    Tolman Z; Chaverra M; George L; Lefcort F
    Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35481599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal and cellular models of familial dysautonomia.
    Lefcort F; Mergy M; Ohlen SB; Ueki Y; George L
    Clin Auton Res; 2017 Aug; 27(4):235-243. PubMed ID: 28667575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent regulation of ELP1 exon 20 splicing in Familial Dysautonomia by RNA Polymerase II kinetics and chromatin structure.
    Riccardi F; Romano G; Licastro D; Pagani F
    PLoS One; 2024; 19(6):e0298965. PubMed ID: 38829854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Elp1 disrupts trigeminal ganglion neurodevelopment in a model of familial dysautonomia.
    Leonard CE; Quiros J; Lefcort F; Taneyhill LA
    Elife; 2022 Jun; 11():. PubMed ID: 35713404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.